Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 08-2018 | 05-2018 | 02-2018 | 11-2017 | 08-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,749 | 1,231 | 4,947 | 1,297 | 946 |
| TOTAL | $7,540 | $3,321 | $6,617 | $4,735 | $4,282 |
| Non-Current Assets | |||||
| PPE Net | 12 | 11 | 12 | 14 | 16 |
| Intangibles | 1,480 | 1,567 | 1,655 | 1,742 | 1,830 |
| TOTAL | $1,492 | $1,578 | $1,667 | $1,756 | $1,845 |
| Total Assets | $9,031 | $4,899 | $8,285 | $6,491 | $6,128 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,816 | 15,842 | 11,655 | 9,717 | 5,670 |
| Accrued Expenses | 868 | 891 | 933 | 1,625 | 943 |
| TOTAL | $24,139 | $16,733 | $12,588 | $16,734 | $11,108 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,690 | 1,324 | 3,289 | 2,548 | 3,377 |
| TOTAL | $4,690 | $1,324 | $3,289 | $2,548 | $3,377 |
| Total Liabilities | $28,829 | $18,057 | $15,877 | $19,281 | $14,485 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 255,763 | 218,693 | 212,083 | 169,862 | 156,100 |
| Common Shares | 234 | 217 | 209 | 165 | 153 |
| Retained earnings | -187,553 | -173,139 | -163,516 | -145,566 | -134,618 |
| TOTAL | $-19,797 | $-13,158 | $-7,593 | $-12,791 | $-8,358 |
| Total Liabilities And Equity | $9,032 | $4,899 | $8,285 | $6,491 | $6,128 |